Drugs / AVANZ Salsola
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02065856 | Dec 2013 → Aug 2014 | allergic rhinitis | ALK-Abelló A/S | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AVANZ Salsola | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02065856 ↗ |
| Route | Subcutaneous | “Subcutaneous immunotherapy” NCT02065856 ↗ |